文献速递瓣膜病与结构性心脏病

心外膜脂肪组织与无症状主动脉瓣狭窄患者心肌重构及不良结局:一项随机对照试验的事后分析

Epicardial adipose tissue, myocardial remodelling and adverse outcomes in asymptomatic aortic stenosis: a post hoc analysis of a randomised controlled trial.
PubMed 文献 · Heart · 2025-06-26

该研究对124例无症状轻至重度主动脉瓣狭窄患者进行事后分析,采用深度学习软件在CT血管造影上量化基线心外膜脂肪组织。结果显示心外膜脂肪组织体积与主动脉瓣狭窄严重程度或进展无关,但与心肌损伤标志物及全因死亡风险增加相关。

要点

  • 心外膜脂肪组织体积与主动脉瓣狭窄严重程度及进展无关。
  • 心外膜脂肪组织体积与心肌肌钙蛋白、左室质量等心肌健康受损标志物相关。
  • 心外膜脂肪组织体积>90 mm³者全因死亡风险增加3-4倍。

核心结论

  • 心外膜脂肪组织体积与无症状主动脉瓣狭窄的严重程度或进展无关,但与心肌健康受损的生物标志物相关,后者可能解释其与全因死亡风险增加的关系。

研究设计与样本

  • 随机对照试验的事后分析,纳入124例无症状轻至重度主动脉瓣狭窄患者,基线心外膜脂肪组织通过CT血管造影使用全自动深度学习软件量化。

主要发现

  • 心外膜脂肪组织体积和衰减与主动脉瓣狭窄严重程度或后续疾病进展均无相关性(所有p>0.05)。
  • 心外膜脂肪组织体积与血浆心肌肌钙蛋白浓度(r=0.23,p=0.009)、左心室质量(r=0.46,p<0.001)、射血分数(r=-0.28,p=0.002)、整体纵向应变(r=0.28,p=0.017)和左心房容积(r=0.39,p<0.001)相关。
  • 中位随访48(IQR 26-73)个月期间,共23例(18%)患者死亡。
  • 多变量分析中,调整年龄、体重指数和左心室射血分数后,心外膜脂肪组织体积(HR 1.82,95%CI 1.10至3.03;p=0.021)和血浆心肌肌钙蛋白浓度(HR 1.47,95%CI 1.13至1.90;p=0.004)与全因死亡率相关。
  • 心外膜脂肪组织体积>90 mm³的患者死亡风险增加3-4倍(调整后HR 3.74,95%CI 1.08至12.96;p=0.037)。

临床怎么用

  • 在无症状主动脉瓣狭窄患者中,心外膜脂肪组织体积可能有助于识别心肌健康受损和死亡风险较高的个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Epicardial adipose tissue represents a metabolically active visceral fat depot that is in direct contact with the left ventricular myocardium. While it is associated with coronary artery disease, little is known regarding its role in aortic stenosis. We sought to investigate the association of epicardial adipose tissue with aortic stenosis severity and progression, myocardial remodelling and function, and mortality in asymptomatic patients with aortic stenosis. METHODS: In a post hoc analysis of 124 patients with asymptomatic mild-to-severe aortic stenosis participating in a prospective clinical trial, baseline epicardial adipose tissue was quantified on CT angiography using fully automated deep learning-enabled software. Aortic stenosis disease severity was assessed at baseline and 1 year. The primary endpoint was all-cause mortality. RESULTS: Neither epicardial adipose tissue volume nor attenuation correlated with aortic stenosis severity or subsequent disease progression as assessed by echocardiography or CT (p>0.05 for all). Epicardial adipose tissue volume correlated with plasma cardiac troponin concentration (r=0.23, p=0.009), left ventricular mass (r=0.46, p<0.001), ejection fraction (r=-0.28, p=0.002), global longitudinal strain (r=0.28, p=0.017), and left atrial volume (r=0.39, p<0.001). During the median follow-up of 48 (IQR 26-73) months, a total of 23 (18%) patients died. In multivariable analysis, both epicardial adipose tissue volume (HR 1.82, 95% CI 1.10 to 3.03; p=0.021) and plasma cardiac troponin concentration (HR 1.47, 95% CI 1.13 to 1.90; p=0.004) were associated with all-cause mortality, after adjustment for age, body mass index and left ventricular ejection fraction. Patients with epicardial adipose tissue volume >90 mm3 had 3-4 times higher risk of death (adjusted HR 3.74, 95% CI 1.08 to 12.96; p=0.037). CONCLUSIONS: Epicardial adipose tissue volume does not associate with aortic stenosis severity or its progression but does correlate with blood and imaging biomarkers of impaired myocardial health. The latter may explain the association of epicardial adipose tissue volume with an increased risk of all-cause mortality in patients with asymptomatic aortic stenosis. CLINICALTRIALS: gov (NCT02132026).

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Geers J, Manral N, Razipour A, et al. Epicardial adipose tissue, myocardial remodelling and adverse outcomes in asymptomatic aortic stenosis: a post hoc analysis of a randomised controlled trial. Heart. 2025. PMID: 40050004. doi:10.1136/heartjnl-2024-324925

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。